Clinical Trial Update: Liposomal Bupivacaine (Exparel ® ) Plus 0.5% Bupivacaine HCL Versus 0.5% Bupivacaine HCL for Interscalene Nerve Block (ISB) for Patients Undergoing Total Shoulder Arthroplasty(TSA) [Phase 4]

View source ↗

Summary

Phase 4 trial comparing liposomal bupivacaine (Exparel) plus 0.5% bupivacaine to 0.5% bupivacaine alone for interscalene nerve block in total shoulder arthropla…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Shoulder Arthroplasty
• Shoulder Pain

Drugs mentioned

• 0.5% bupivacaine HCL (bupivacaine hydrochloride)
• Exparel (liposomal bupivacaine)

Snippet

Sponsor: NYU Langone Health | Conditions: Shoulder Pain | Phase 4 | Status: COMPLETED | Results posted: 2022-02-01